lansoprazole has been researched along with Gynecomastia in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Gynecomastia: Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Comas, A | 1 |
Salgueiro, E | 1 |
Hidalgo, A | 1 |
Cuervo Martín, JR | 1 |
García Ortega, P | 1 |
Sánchez Sánchez, A | 1 |
Carvajal García-Pando, A | 1 |
2 other studies available for lansoprazole and Gynecomastia
Article | Year |
---|---|
[Lansoprazole-induced gynecomastia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Gynecomastia; H | 2000 |
[Gynecomastia associated with the simultaneous use of cisapride and lansoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Cisapride; Drug Combinations; Gast | 2001 |